Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis

Journal of Clinical Investigation

Volumn 98, Issue 7, 1996, Pages 1544-1549

  Guise, Theresa A ^a,c   Yin, Juan Juan ^a   Taylor, Suzanne D ^a   Kumagai, Yoshinari ^b   Dallas, Mark ^a   Boyce, Brendan F ^a   Yoneda, Toshiyuki ^a   Mundy, Gregory R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Big Bear Bio Inc   (United States)

^c Department of Medicine ^*  (United States)

Author keywords

bone metastases; hypercalcemia; malignancy; osteoclast; parathyroid hormone related protein

Indexed keywords

PARATHYROID HORMONE RELATED PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE METASTASIS; BREAST CANCER; CONTROLLED STUDY; FEMALE; HYPERCALCEMIA; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 10144241022     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118947     Document Type: Article

References (28)

1. Boyde, A., E. Maconnachie, S.A. Reid, G. Delling, and G.R. Mundy. 1986. Scanning electron microscopy in hone pathology: review of methods. Potential and applications. Scanning Electron Microsc. (Pt 4):1537-1554.
2. Coleman, R.E., and R.D. Rubens. 1987. The clinical course of hone metastases from breast cancer. Br. J. Cancer. 55:61-66.
3. Stewart, A.F., R. Horst, L.J. Deftos, E.C. Cadman, R. Lang, and A.E. Broadus. 1980. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N. Engl. J. Med. 303:1377-1383.
4. Burtis, W.J., T.F. Bady, J.J. Orloff, J.B. Ersbak, R.P. Warrell, B.R. Olson, T.L. Wu, M.E. Mitnick, A.E. Broadus, and A.F. Stewart. 1990. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N. Engl. J. Med. 322:1106-1112.
5. Powell, G.J., J. Southby, J.A. Danks, R.G. Stillwell, J.A. Hayman, M.A. Henderson, R.C. Bennett, and T.J. Martin. 1991. Localization of parathyroid hormone-related protein in breast cancer metastasis: increased incidence in bone compared with other sites. Cancer Res. 51:3059-3061.
6. Southby, J., M.W. Kissin, J.A. Danks, J.A. Hayman, J.M. Moseley, M.A. Henderson, R.C. Bennett, and T.J. Martin. 1990. Immunohistochemical localization of parathyroid hormone-related protein in breast cancer. Cancer Res. 50:7710-7716.
7. Bundred, N.J., W.A. Ratcliffe, R.A. Walker, S. Coley, J.M. Morrison, and J.G. Ratcliffe. 1991. Parathyroid hormone related protein and hypercalcaemia in breast cancer. BMJ. 303:1506-1509.
8. Guise, T.A., T. Yoneda, A.J. Yates, and G.R. Mundy. 1993. The combined effect of tumor-produced parathyroid hormone-related peptide and transforming growth factor-α enhance hypercalcemia in vivo and bone resorption in vitro. J. Clin. Endocrinol. Metab. 77:40-45.
9. Cailleau, R., R. Yong, M. Olive, and W.J. Reeves. 1974. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 53:661-674.
10. Sato, K., Y. Yamakawa, K. Shizume, T. Satoh, K., Nohtomi, H. Demura, T. Akatsu, N. Nagata, T. Kasahara, H. Ohkawa et al. 1993. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors. J. Bone Miner. Res. 8:849-860.
11. Arguello, F., R.B. Baggs, and C.N. Frantz. 1988. A murine model of experimental metastasis to bone and bone marrow. Cancer Res. 48:6878-6881.
12. Pandian, M.R., C.H. Morgan, E. Carlton, and G.V. Segre. 1992. Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia. Clin. Chem. 38:282-288.
13. Budayr, A.A., R.A. Nissenson, R.F. Klein, K.K. Pun, O.H. Clark, D. Diep, C.D. Arnaud, and G.J. Strewler. 1989. Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia. Ann. Intern. Med. 111:807-812.
14. Grill, V., P. Ho, J.J. Body, N. Johanson, S.C. Lee, S.C. Kukreja, J.M. Mosely, and T.J. Martin. 1991. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia and hypercalcemia complicating metastatic breast cancer. J. Clin. Endocrinol Metab. 73:1309-1315.
15. Burtis, W.J., T. Wu, C. Bunch, J. Wysolmerski, K. Insogna, E. Weir, A.E. Broadus, and A.F. Stewart. 1987. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J. Biol. Chem. 262:7151-7156.
16. Strewler, G.J., P.H. Stern, J.W. Jacobs, J. Eveloff, R.F. Klein, S.C. Leung, M. Rosenblatt, and R.A. Nissenson. 1987. Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J. Clin. Invest. 80:18113-1807.
17. Moseley, J.M., M. Kubota, H. Diefenbach-Jagger, R.E.H. Wettenhall, B.E. Kemp, L.J. Suva, C.P. Rodda, P.R. Ebeling, P.J. Hudson, J.D. Zajac, and T.J. Martin. 1987. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc. Natl. Acad. Sci. USA. 84:5048-5052.
18. Bundred, N.J., R.A. Walker, W.A. Ratcliffe, J. Warwick, J.M. Morrison, and J.G. Ratcliffe. 1992. Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur. J. Cancer 28:690-692.
19. Manolagas, S.C. 1995. Role of cytokines in bone resorption. Bone. 17: 63-67.
20. De La Mata, J., H.L. Uy, T.A. Guise, B. Story, B.F. Boyce, G.R. Mundy, and G.D. Roodman. 1995. Interleuken-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J. Clin. Invest. 95:2846-2852.
21. Rizzoli, R., J.H.M. Feyen, G. Grau, A. Wohlwend, A.P. Sappino, and J.-P. Bonjour. 1994. Regulation of parathyroid hormone-related protein production in a human lung squamous cell carcinoma line. J. Endocrinol. 143:333-341.
22. Horiuchi, N., M. Caulfield, J.E. Fisher, M. Goldman, R. Mckee, J. Reagan, J. Levy, R. Nutt, S. Rodan, T. Schoefield, T. Clemens, and M. Rosenblatt. 1987. Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro. Science (Wash. DC). 238:1566-1568.
23. Hauschka, P.V., A.E. Mavrakos, M.D. Iafrati, S.E. Doleman, and M. Klagsbrun. 1986. Growth factors in bone matrix. J. Biol. Chem. 261:12665-12674.
24. Pfeilschifter, J., and G.R. Mundy. 1987. Modulation of transforming growth factor β activity in bone cultures by osteotropic hormones. Proc. Natl. Acad. Sci. USA. 84:2024-2028.
25. Guise, T.A., S.D. Taylor, T. Yoneda, A. Sasaki, K. Wright, B.F. Boyce, J.M. Chirgwin, and G.R. Mundy. 1994. PTHrP expression by breast cancer cells enhance osteolytic bone metastases in vivo. J. Bone Miner. Res. 9(Suppl. 1)33: 128a. (Abstr.)
26. Kiriyama, T., M.T. Gillespie, J.A. Glatz, S. Fukumoto, J.M. Moseley, and T.J. Martin. 1992. Transforming growth factor β stimulation of parathyroid hormone-related protein (PTHrP): a paracrine regulator? Mol. Cell. Endocrinol. 92:55-62.
27. Yoneda, T., P. Williams, C. Dunstan, J. Chavez, M. Niewolna, and G.R. Mundy. 1995. Growth of metastatic cancer cells in bone is enhanced by bone-derived insulin-like growth factors. J. Bone. Miner. Res. 10(Suppl. 1)P269a: 196a. (Abstr.)
28. Sasaki, A., B.F. Boyce, B. Story, K.R. Wright, M. Chapman, R. Boyce, G.R. Mundy, and T. Yoneda. 1995. The bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res. 55: 3351-3357.